ClinicalTrials.gg
CompletedNCT06388265Updated Nov 19, 2025

Emotional and Oral Characteristics of Patients That Attend a Dental Consultation for the Extraction of Third Molars

An interventional study of Trifold information in Anxiety and Fear, sponsored by University of Barcelona. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-19.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by University of Barcelona · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 3 months after the study started (first participant enrolled Jan 2022, registered Apr 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Analyze the level of anxiety, hemodynamic parameters, oral status, and satisfaction among patients undergoing third molar extraction, we will assess those who attend the Master of Oral Medicine, Surgery, and Implantology program at the University of Barcelona.

02

Conditions studied

  • Anxiety and Fear

Browse trials for

03

In context

Anxiety Disorders Unverified

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

This study's enrollment of 82 is close to the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University of Barcelona is the lead sponsor of 100 studies on the registry; 30 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals 18 years old or older, from both genders that wished to voluntarily participate in the study and that required the extraction of third molars.

Exclusion criteria

Exclusion Criteria:

  • Systemic diseases () that contraindicate the performance of the surgical procedure
  • Pregnant women
  • Individuals that did not understand and/or could not respond the given questionnaire.
  • Patients that required the extraction of a different tooth than a third molar or that required the extraction of more than two third molars in the same surgical time.
  • Patients who had undergone extraction of a third molar in the twelve months prior to the current visit.
  • Patients taking antidepressant medication or anxiolytic medication
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Verbal and Written detailed information

    The experimental group will receive verbal information about the procedure (exodontia of third molars) and additionally a trifold with detailed information about the surgical procedure.

    Other: Trifold information

  • No intervention
    Control

    The control group will only receive verbal information about the surgical procedure.

Interventions

  • OtherTrifold information

    Additional detailed and written information about the procedure will be given to the participants

06

What researchers measure

Primary outcomes

  1. Changes in STAI-S

    The Anxiety State scale (S-Anxiety) is an inventory that has been validated and assesses the current state of anxiety of the participant measured through an auto evaluation, asking how the evaluated individual feels "in this moment", using items that measure subjective feelings of apprehension, tension, nervousness, worry and activation/excitement of the autonomic nervous system. The total scores can go from 20 to 80 points A cut point value of 39 to 40 points has been suggested to detect clinically significant symptoms in the Anxiety State scale. STAI-S will be assessed in 4 stages: 1. At the initial consultation (baseline) 2. Immediately before the procedure and administration of the local anaesthetic solution 3. Immediately after the procedure is completed 4. 1 week after the procedure (exodontia)

    Time frame: Through study completion, an average of 5 weeks

  2. Changes in MDAS

    The modified dental anxiety scale (MDAS) is an auto evaluation questionnaire about dental anxiety that contains 5 items, each one with 5 possible answers that reflects in order an increase of anxiety (no anxiety to extremely anxious). The total score can go from 5 points to a maximum of 25 points. The lower limit to define an individual with extreme anxiety is 19 points and to define the presence of anxiety the score must be higher than 10 points. MDAS will be assessed in 2 stages: 1. At the initial consultation (baseline) 2. Immediately before the procedure and administration of the local anaesthetic solution

    Time frame: up to 3 weeks

Secondary outcomes

  1. Changes in blood pressure

    Changes in Blood pressure (Systolic and dyastolic) measured in mmHg Blood pressure will be assessed in 5 stages: 1. At the initial consultation (baseline) 2. Immediately before the procedure and administration of the local anaesthetic solution 3. Immediately after administration of the local anaesthetic solution 4. Immediately after the procedure is completed

    Time frame: Through study completion, an average of 5 weeks

  2. Changes in Heart rate

    Changes in heart rate measured in beats per minute Heart rate will be assessed in 5 stages: 1. At the initial consultation (baseline) 2. Immediately before the procedure and administration of the local anaesthetic solution 3. Immediately after administration of the local anaesthetic solution 4. Immediately after the procedure is completed

    Time frame: Through study completion, an average of 5 weeks

  3. Changes in Oxygen saturation

    Changes in oxygen saturation measured in percentage (%) Oxygen saturation will be assessed in 5 stages: 1. At the initial consultation (baseline) 2. Immediately before the procedure and administration of the local anaesthetic solution 3. Immediately after administration of the local anaesthetic solution 4. Immediately after the procedure is completed

    Time frame: Through study completion, an average of 5 weeks

  4. Patient Satisfaction of procedure

    A questionnaire will be provided to the participants that consists of 6 questions, 2 questions to know the degree of discomfort at the last visit (suture removal control post exodontia) with 4 possible answers: none, little, moderate, a lot; and 4 questions to determine the degree of satisfaction with all the dental treatment carried out with affirmative or negative answers

    Time frame: 1 week after the procedure

07

Study locations

1 site
  • Hospital Odontològic Universitat de Barcelona
    L'Hospitalet de Llobregat, Barcelona 08907, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2022 to primary completion in Jul 2025, 42 months.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 42 months is above that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 20, 2024
First posted
Apr 29, 2024
StartActual
Jan 9, 2022
Primary completionActual
Jul 31, 2025
CompletionActual
Jul 31, 2025
Last update
Nov 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06388265
Responsible party
Mayra Schemel Suarez (Principal Investigator, University of Barcelona) — Principal investigator
First posted
Apr 29, 2024
Start date
Jan 9, 2022
Primary completion
Jul 31, 2025
Completion
Jul 31, 2025
Last update
Nov 19, 2025

Study contacts

José López-López, PhD
study director · University of Barcelona
Mayra Schemel Suarez, DDS
principal investigator · University of Barcelona

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion